TrialThe Lancet. Global health2023

A cardiovascular polypill for secondary stroke prevention in a tertiary centre in Ghana (SMAART): a phase 2 randomised clinical trial.

Fred Stephen Sarfo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.